Physician profile
Douglas E Kyle
NPI 1366408924
$1,131.84
in general payments reported to CMS, 2019-2025
29 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $94.14 · 2021: $201 · 2022: $225 · 2023: $199 · 2024: $194 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $304.66 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $81.75 | 2023-2025 | |
| Daiichi Sankyo INC. | $67.75 | 2020-2022 | |
| Exeltis, USA INC. | $66.49 | 2022-2025 | Slynd |
| Pfizer INC. | $50.49 | 2023-2024 | |
| Medtronic, INC. | $48.71 | 2022-2024 | Ligasure |
| Shield Therapeutics INC | $43.69 | 2023 | Accrufer |
| Astellas Pharma US INC | $36.73 | 2022-2023 | Veozah |
| Monaghan Medical Corporation | $35.80 | 2024 | Aerochamber |
| Organon LLC | $35.39 | 2024 | |
| Evofem Biosciences, INC. | $33.48 | 2021 | |
| Novo Nordisk INC | $33.43 | 2025 | Wegovy |
| Northgate Technologies, INC. | $26.35 | 2024 | Stimsite |
| Myovant Sciences INC. | $22.88 | 2022 | |
| Roche Diagnostics Corporation | $22.73 | 2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $22.64 | 2024 | Stratafix, Harmonic, Surgicel Nu-Knit |
| Molnlycke Health Care US, LLC | $22.13 | 2024 | Avance, Mepilex Border Post-Op Ag |
| Therapeuticsmd, INC. | $20.36 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $18.03 | 2023 | Exparel |
| Medicem INC. | $17.50 | 2022 | |
| Aspira Women'S Health INC | $17.30 | 2022 | |
| Stryker Corporation | $15.73 | 2025 | 1788 |
| Conmed Corporation | $14.43 | 2025 | Airseal |
| Avion Pharmaceuticals | $13.45 | 2019 | |
| Currax Pharmaceuticals LLC | $12.99 | 2023 | Contrave |
| Mission Pharmacal Company | $12.54 | 2021 | |
| Coopersurgical, INC. | $12.30 | 2022 | |
| Minerva Surgical, INC | $12.29 | 2022 | |
| Biomerieux INC | $9.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Kyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.